313 related articles for article (PubMed ID: 15128815)
1. Cellular and humoral immunity against vaccinia virus infection of mice.
Xu R; Johnson AJ; Liggitt D; Bevan MJ
J Immunol; 2004 May; 172(10):6265-71. PubMed ID: 15128815
[TBL] [Abstract][Full Text] [Related]
2. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.
Mathurin KS; Martens GW; Kornfeld H; Welsh RM
J Virol; 2009 Apr; 83(8):3528-39. PubMed ID: 19193795
[TBL] [Abstract][Full Text] [Related]
3. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
[TBL] [Abstract][Full Text] [Related]
4. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
Xi Y; Day SL; Jackson RJ; Ranasinghe C
Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells.
Zhong W; Roberts AD; Woodland DL
J Immunol; 2001 Aug; 167(3):1379-86. PubMed ID: 11466356
[TBL] [Abstract][Full Text] [Related]
7. Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.
Larsen IV; Clausius H; Kolb AW; Brandt CR
J Virol; 2016 Jul; 90(14):6557-6572. PubMed ID: 27170749
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
9. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
10. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Klinman D; Berzofsky JA
J Immunol; 2006 Nov; 177(9):6336-43. PubMed ID: 17056564
[TBL] [Abstract][Full Text] [Related]
12. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
13. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.
Binder D; Kündig TM
J Immunol; 1991 Jun; 146(12):4301-7. PubMed ID: 1710246
[TBL] [Abstract][Full Text] [Related]
14. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.
Yeh N; Glosson NL; Wang N; Guindon L; McKinley C; Hamada H; Li Q; Dutton RW; Shrikant P; Zhou B; Brutkiewicz RR; Blum JS; Kaplan MH
J Immunol; 2010 Aug; 185(4):2089-98. PubMed ID: 20624947
[TBL] [Abstract][Full Text] [Related]
15. Primary and secondary immunocompetence in mixed allogeneic chimeras.
Williams MA; Adams AB; Walsh MB; Shirasugi N; Onami TM; Pearson TC; Ahmed R; Larsen CP
J Immunol; 2003 Mar; 170(5):2382-9. PubMed ID: 12594261
[TBL] [Abstract][Full Text] [Related]
16. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
17. Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.
Uhrlaub JL; Brien JD; Widman DG; Mason PW; Nikolich-Zugich J
J Immunol; 2011 Apr; 186(7):3882-91. PubMed ID: 21339368
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
19. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
[TBL] [Abstract][Full Text] [Related]
20. Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.
Tian T; Dubin K; Jin Q; Qureshi A; King SL; Liu L; Jiang X; Murphy GF; Kupper TS; Fuhlbrigge RC
J Invest Dermatol; 2012 May; 132(5):1425-34. PubMed ID: 22318381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
